These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Challenges of turning nucleic acids into therapeutics. Mahato RI Adv Drug Deliv Rev; 2000 Nov; 44(2-3):79-80. PubMed ID: 11072106 [No Abstract] [Full Text] [Related]
4. Recent advances in dendrimer-based nanovectors for tumor-targeted drug and gene delivery. Kesharwani P; Iyer AK Drug Discov Today; 2015 May; 20(5):536-47. PubMed ID: 25555748 [TBL] [Abstract][Full Text] [Related]
5. Emerging Concepts in Gene Therapy for Osteoarthritis. Rai MF; Sandell LJ J Am Acad Orthop Surg; 2015 Oct; 23(10):e56-7. PubMed ID: 26320162 [No Abstract] [Full Text] [Related]
7. Applications of Virus Vector-Mediated Gene Therapy in China. Lin Q; Wang DG; Zhang ZQ; Liu DP Hum Gene Ther; 2018 Feb; 29(2):98-109. PubMed ID: 29284296 [TBL] [Abstract][Full Text] [Related]
8. Non-viral nucleic acid delivery: key challenges and future directions. Elsabahy M; Nazarali A; Foldvari M Curr Drug Deliv; 2011 May; 8(3):235-44. PubMed ID: 21291381 [TBL] [Abstract][Full Text] [Related]
9. Chitosan nanoparticles as non-viral gene delivery systems: determination of loading efficiency. Carrillo C; Suñé JM; Pérez-Lozano P; García-Montoya E; Sarrate R; Fàbregas A; Miñarro M; Ticó JR Biomed Pharmacother; 2014 Jul; 68(6):775-83. PubMed ID: 25092239 [TBL] [Abstract][Full Text] [Related]
10. Recent progress in gene therapy to deliver nucleic acids with multivalent cationic vectors. Junquera E; Aicart E Adv Colloid Interface Sci; 2016 Jul; 233():161-175. PubMed ID: 26265376 [TBL] [Abstract][Full Text] [Related]
11. Introducing Genes to the Heart: All About Delivery. Hajjar RJ; Ishikawa K Circ Res; 2017 Jan; 120(1):33-35. PubMed ID: 28057788 [TBL] [Abstract][Full Text] [Related]
12. A non-viral vector for in vivo gene delivery. Thomas L Lancet Neurol; 2005 Oct; 4(10):602. PubMed ID: 16208875 [No Abstract] [Full Text] [Related]
13. The third annual BRDS on research and development of nucleic acid-based nanomedicines. Chaudhary AK; Mahato RI Drug Deliv Transl Res; 2017 Feb; 7(1):188-193. PubMed ID: 27848223 [TBL] [Abstract][Full Text] [Related]
14. [Gene therapy - successes and many unsolved questions]. Bruhn C Dtsch Med Wochenschr; 2014 Sep; 139(39):1916-7. PubMed ID: 25360466 [No Abstract] [Full Text] [Related]
15. New era in gene therapy: end of the beginning. Morishita R Expert Opin Biol Ther; 2015 Mar; 15(3):309-10. PubMed ID: 25686245 [No Abstract] [Full Text] [Related]
17. Nanomedicines and nanodiagnostics come of age. Uchegbu IF; Siew A J Pharm Sci; 2013 Feb; 102(2):305-10. PubMed ID: 23175462 [TBL] [Abstract][Full Text] [Related]
18. [Gene therapy in Germany: from past to present]. Kim Y; Schmidt-Wolf IG Dtsch Med Wochenschr; 2015 Apr; 140(9):684-6. PubMed ID: 25924050 [TBL] [Abstract][Full Text] [Related]
19. Current status and recent advances of gene therapy in hematological diseases. Yamamoto M; Tani K Int J Hematol; 2016 Jul; 104(1):4-5. PubMed ID: 27250344 [No Abstract] [Full Text] [Related]
20. Five years of vector service for gene therapy. Mezzina M; Danos O Trends Genet; 2002 Mar; 18(3):118-9. PubMed ID: 11858829 [No Abstract] [Full Text] [Related] [Next] [New Search]